The World Health Organization on Wednesday laid out three possible paths that the COVID-19 pandemic might follow in 2022—with a new, more virulent variant the worst-case scenario.
Mar 30, 2022
0
30
People with the "hybrid immunity" of having been both fully vaccinated and previously infected with COVID-19 have the strongest protection against the virus, two new studies said on Friday.
Apr 1, 2022
0
207
The omicron variant of SARS-CoV-2 is spreading at an alarming rate. It could soon replace the delta variant, which at present dominates globally. However, little is known about whether currently available vaccines and drugs ...
Dec 29, 2021
2
931
Now it's "longer COVID." New figures from the Office for National Statistics (ONS) show 30% of long COVID sufferers have had symptoms for more than two years. New cases of long COVID are also increasing just as the new "Kraken" ...
Jan 12, 2023
0
638
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months. Initial epidemiological ...
Jan 7, 2022
2
528
The World Health Organization lamented Tuesday that half a million COVID-19 deaths had been recorded since the Omicron variant was discovered, calling the toll "beyond tragic".
Feb 8, 2022
1
57
A team of researchers with members from the Gladstone Institute and Curative Inc. has uncovered new attributes of the SARS-CoV-2 omicron variant that could explain why it is so much more transmissible than other variants ...
The SARS-CoV-2 Alpha (B.1.1.7) variant mutated to evade our 'innate immune system', helping establish it as the world's first 'Variant of Concern', finds a new study led by researchers at UCL and the Quantitative Biosciences ...
Dec 23, 2021
0
498
Investigators have identified more than 60 previously unknown genetic variants associated with resting heart rate that may also contribute to increased risk of cardiovascular disease, according to recent findings published ...
Sep 8, 2023
0
85
Research led by the Université Paris Cité, CNRS, France, has investigated factors driving variability in diverse immune responses to SARS-CoV-2.
